BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home » Authors » John Fox

Articles by John Fox

Study suggests new approach to treating RAS-driven cancers

April 1, 2015
By John Fox
HONG KONG – In a landmark study, Singapore-based researchers have identified a novel kinase feedback loop controlling autophagy in common RAS-driven cancers and have shown that combining a kinase inhibitor with an agent that prevents autophagy may offer an effective new approach to treating such tumors.
Read More

Study suggests new approach to treating RAS-driven cancers

April 1, 2015
By John Fox
HONG KONG – In a landmark study, Singapore-based researchers have identified a novel kinase feedback loop controlling autophagy in common RAS-driven cancers and have shown that combining a kinase inhibitor with an agent that prevents autophagy may offer an effective new approach to treating such tumors.
Read More

LDH inhibition shows promise for drug-resistant epilepsy

March 25, 2015
By John Fox
HONG KONG – Inhibition of lactate dehydrogenase (LDH) blocked the characteristic neuronal excitation seen in epileptic seizures in vitro and prevented such events in a mouse model of epilepsy in a study by Japanese pharmacologists, who also identified a promising new treatment for patients with drug-resistant epilepsy.
Read More

LDH inhibition shows promise for drug-resistant epilepsy

March 24, 2015
By John Fox
HONG KONG – Inhibition of lactate dehydrogenase (LDH) blocked the characteristic neuronal excitation seen in epileptic seizures in vitro and prevented such events in a mouse model of epilepsy in a study by Japanese pharmacologists, who also identified a promising new treatment for patients with drug-resistant epilepsy.
Read More

Pre-op ANP boosts lung cancer surgery survival

March 20, 2015
By John Fox
HONG KONG – Preoperative atrial natriuretic peptide (ANP) improved survival in lung cancer patients undergoing surgery and appeared to prevent cancer metastasis through prevention of vascular endothelial inflammation and adhesion in mice, Japanese researchers reported in the March 16, 2015, early edition of the Proceedings of the National Academy of Sciences.
Read More

Return to pre-antibiotic era? AMR hits developing countries the hardest

March 11, 2015
By John Fox
HONG KONG – New antibiotic agents are urgently needed to overcome the burgeoning problem of antimicrobial resistance (AMR) in infectious bacteria, but novel agents alone may not be sufficient to prevent a return to the dark days of the pre-antimicrobial era, an infectious disease specialist has warned.
Read More

Return to pre-antibiotic era? AMR hits developing countries hardest

March 10, 2015
By John Fox
HONG KONG – New antibiotic agents are urgently needed to overcome the burgeoning problem of antimicrobial resistance in infectious bacteria, but novel agents alone may not be sufficient to prevent a return to the dark days of the pre-antimicrobial era, an infectious disease specialist has warned.
Read More

Researchers find a powerful new dengue neutralizing antibody

March 4, 2015
By John Fox
HONG KONG – A study led by Singaporean researchers has identified a potent new antibody against the dengue virus, a minimal amount of which is required to neutralize it, which is an important finding that may lead to the development of effective new treatments or vaccines.
Read More

Researchers find a powerful new dengue neutralizing antibody

March 3, 2015
By John Fox
HONG KONG – A study led by Singaporean researchers has identified a potent new antibody against the dengue virus, a minimal amount of which is required to neutralize it, which is an important finding that may lead to the development of effective new treatments or vaccines.
Read More

Common heart drug interactions traced to vitamin K: study

Feb. 25, 2015
By John Fox
HONG KONG — The results of a study by Japanese researchers from the University of Tokyo have helped to elucidate the previously unknown underlying mechanism whereby two commonly prescribed drugs in patients at risk for heart disease can adversely interact, a finding that could lead to improved clinical care of patients taking those medications.
Read More
Previous 1 2 … 56 57 58 59 60 61 62 63 64 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Xray showing lung cancer on tablet

    How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III

    BioWorld
    Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing